Pharma Aids Statistics

Total Valuation

Pharma Aids has a market cap or net worth of BDT 1.73 billion. The enterprise value is 1.73 billion.

Market Cap	1.73B
Enterprise Value	1.73B

Important Dates

The next estimated earnings date is Sunday, April 27, 2025.

Earnings Date	Apr 27, 2025
Ex-Dividend Date	Dec 8, 2024

Share Statistics

Pharma Aids has 3.12 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	3.12M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 27.69.

PE Ratio	27.69
Forward PE	n/a
PS Ratio	4.01
PB Ratio	4.28
P/TBV Ratio	4.28
P/FCF Ratio	462.66
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.70, with an EV/FCF ratio of 462.95.

EV / Earnings	27.71
EV / Sales	4.01
EV / EBITDA	18.70
EV / EBIT	20.14
EV / FCF	462.95

Financial Position

The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.08.

Current Ratio	2.75
Quick Ratio	1.24
Debt / Equity	0.08
Debt / EBITDA	0.36
Debt / FCF	9.02
Interest Coverage	126.56

Financial Efficiency

Return on equity (ROE) is 17.36% and return on invested capital (ROIC) is 13.90%.

Return on Equity (ROE)	17.36%
Return on Assets (ROA)	10.45%
Return on Invested Capital (ROIC)	13.90%
Return on Capital Employed (ROCE)	21.15%
Revenue Per Employee	5.02M
Profits Per Employee	726,521
Employee Count	86
Asset Turnover	0.84
Inventory Turnover	4.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.08% in the last 52 weeks. The beta is -0.01, so Pharma Aids's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-14.08%
50-Day Moving Average	536.99
200-Day Moving Average	611.93
Relative Strength Index (RSI)	55.98
Average Volume (20 Days)	16,176

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Aids had revenue of BDT 431.52 million and earned 62.48 million in profits. Earnings per share was 20.03.

Revenue	431.52M
Gross Profit	131.28M
Operating Income	85.96M
Pretax Income	86.36M
Net Income	62.48M
EBITDA	92.59M
EBIT	85.96M
Earnings Per Share (EPS)	20.03

Full Income Statement

Balance Sheet

The company has 32.64 million in cash and 33.72 million in debt, giving a net cash position of -1.08 million or -0.35 per share.

Cash & Cash Equivalents	32.64M
Total Debt	33.72M
Net Cash	-1.08M
Net Cash Per Share	-0.35
Equity (Book Value)	404.04M
Book Value Per Share	129.50
Working Capital	311.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.41 million and capital expenditures -2.67 million, giving a free cash flow of 3.74 million.

Operating Cash Flow	6.41M
Capital Expenditures	-2.67M
Free Cash Flow	3.74M
FCF Per Share	1.20

Full Cash Flow Statement

Margins

Gross margin is 30.42%, with operating and profit margins of 19.92% and 14.48%.

Gross Margin	30.42%
Operating Margin	19.92%
Pretax Margin	20.01%
Profit Margin	14.48%
EBITDA Margin	21.46%
EBIT Margin	19.92%
FCF Margin	0.87%

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.45%.

Dividend Per Share	2.50
Dividend Yield	0.45%
Dividend Growth (YoY)	150.00%
Years of Dividend Growth	1
Payout Ratio	5.25%
Buyback Yield	n/a
Shareholder Yield	0.45%
Earnings Yield	3.61%
FCF Yield	0.22%

Dividend Details

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Pharma Aids has an Altman Z-Score of 9.62.

Altman Z-Score	9.62
Piotroski F-Score	n/a